Replies to post #79204 on Ayala Pharmaceuticals Inc (ADXS)

[Bourbon_on_my_cornflakes]

AFMD, NTGN, Gritstone IPO coming

It is clear that ADXS has lost its lead in neoantigen tech, and is now one of several players trying to interest BP partners.

Mgt must close a deal quickly or be left out at the dance. Reasonable expectations of partnership fees are needed.

$20m per HOT ind = $10 investment (what Gritstone got) is about what should be expected.

Close those deal Ken.